PESCITELLI, LEONARDO
 Distribuzione geografica
Continente #
NA - Nord America 2.741
EU - Europa 1.514
AS - Asia 1.242
SA - Sud America 288
AF - Africa 38
OC - Oceania 14
Totale 5.837
Nazione #
US - Stati Uniti d'America 2.699
RU - Federazione Russa 627
SG - Singapore 360
PL - Polonia 268
CN - Cina 261
BR - Brasile 227
VN - Vietnam 193
HK - Hong Kong 184
IT - Italia 158
IE - Irlanda 149
SE - Svezia 112
KR - Corea 94
FR - Francia 49
DE - Germania 43
FI - Finlandia 32
GB - Regno Unito 30
BD - Bangladesh 24
JP - Giappone 23
AR - Argentina 22
JO - Giordania 21
IN - India 19
CA - Canada 17
CI - Costa d'Avorio 17
AU - Australia 14
MX - Messico 12
CO - Colombia 11
CH - Svizzera 10
ID - Indonesia 9
UA - Ucraina 9
EC - Ecuador 8
TR - Turchia 8
UZ - Uzbekistan 8
CL - Cile 7
IQ - Iraq 7
JM - Giamaica 7
PY - Paraguay 7
CZ - Repubblica Ceca 6
IR - Iran 6
NL - Olanda 6
PK - Pakistan 6
ZA - Sudafrica 5
EG - Egitto 4
ES - Italia 4
IL - Israele 3
MA - Marocco 3
MY - Malesia 3
UY - Uruguay 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
HN - Honduras 2
KE - Kenya 2
LT - Lituania 2
NG - Nigeria 2
OM - Oman 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
BE - Belgio 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
KG - Kirghizistan 1
KW - Kuwait 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VE - Venezuela 1
Totale 5.837
Città #
Santa Clara 774
Warsaw 266
Singapore 237
Ashburn 235
Chandler 203
Dublin 148
Hong Kong 145
Fairfield 144
Seoul 93
Woodbridge 81
San Jose 80
Lawrence 75
Altamura 73
Buffalo 67
Seattle 62
Beijing 59
Houston 56
The Dalles 55
Wilmington 53
Cambridge 52
Ho Chi Minh City 51
Los Angeles 42
Princeton 41
Medford 40
Hanoi 37
Lauterbourg 35
Council Bluffs 26
Florence 24
Tokyo 23
Moscow 21
Hefei 20
Ann Arbor 19
Shanghai 19
São Paulo 19
Munich 18
Rome 18
Abidjan 17
Kent 17
San Diego 16
Da Nang 15
Jacksonville 13
Norwalk 12
Boardman 11
New York 11
Haiphong 10
Boston 9
Helsinki 9
Hải Dương 9
London 9
Melbourne 9
Brooklyn 8
Chicago 8
Atlanta 7
Belo Horizonte 7
Dallas 7
Hillsboro 7
Milan 7
Paris 7
Rio de Janeiro 7
Tashkent 7
Turku 7
Bern 6
Charlotte 6
Frankfurt am Main 6
Guangzhou 6
Kingston 6
Toronto 6
Amsterdam 5
Bengaluru 5
Clifton 5
Falkenstein 5
Izmir 5
Andover 4
Biên Hòa 4
Brno 4
Modena 4
Ottawa 4
Salvador 4
Sorocaba 4
Tianjin 4
Tây Ninh 4
Yubileyny 4
Asunción 3
Baghdad 3
Brasília 3
Cagliari 3
Catanduva 3
El Paso 3
Falls Church 3
Fortaleza 3
Guayaquil 3
Hortolândia 3
Jakarta 3
Karachi 3
Lausanne 3
Mumbai 3
Nha Trang 3
Niterói 3
Porto Alegre 3
Saint Petersburg 3
Totale 3.812
Nome #
The involvement of Smac/DIABLO, p53, NF-kB and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligo skin: protective effects of curcumin and capsaicin 298
Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. 280
Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies. 213
The importance of genetical link in immuno-mediated dermatoses: psoriasis and vitiligo. 199
Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa 198
Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities. 186
Cutaneous sarcoidosis during rituximab treatment for microscopic polyangiitis: An uncommon adverse effect? 172
Secukinumab reduces plasma oxidative stress in psoriasis: A case-based experience 170
A pediatric case of sclerodermatous graft-versus-host disease responsive to ultraviolet A1 phototherapy 144
Reduction in psoriasis related pruritus during biologic therapy* 141
NADPH Oxidase 4 as a Source of Oxidative Stress in Fibroblasts From Patients Affected by Psoriasis 140
Lichen planus triggered by CT-P13 and recurrence during secukinumab treatment 140
Source of oxidative stress in fibroblasts from patients affected by psoriasis 140
Evidence for oxidative stress in the plasma of psoriatic patients: Source of ROS and results of treatments with biologics 135
Interleukin 22 early affects keratinocyte differentiation, but not proliferation, in a three-dimensional model of normal human skin. 135
Cutaneous hyperpigmentation induced by apremilast 133
Possible reconsideration of the Nail Psoriasis Severity Index (NAPSI) score 132
Intellectual Disability and Hidradenitis Suppurativa 131
Clinical experience with the etanercept biosimilar SB4 in psoriatic patients 130
Hidradenitis suppurativa and associated diseases 128
Epidermal barrier reaction to an in vitro psoriatic microenvironment 128
Comment on “Oral lichenoid reaction in a psoriatic patient treated with secukinumab: A drug-related rather than a class-related adverse event?” 124
Vitiligo masks malignant acanthosis nigricans in a woman with ovarian cancer 123
Safety and efficacy of HCV eradication during etanercept treatment for severe psoriasis 123
Clinical characteristics of psoriasis in inflammatory bowel disease patients 123
First case of secukinumab successful therapy in a very elderly psoriatic patient 122
Effect of a psoriatic microenvironment in a three-dimensional model of normal human skin 117
Erythrodermic psoriasis treated with ustekinumab: An Italian multicenter retrospective analysis 116
Clinical experience with infliximab biosimilar in psoriasis 116
Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice 109
Curcumin and capsaicin prevent mitochondrial damage and apoptosis in keratinocytes from perilesional vitiligo skin 108
Tuberculosis reactivation risk in dermatology 100
Novel therapeutic approaches and targets for the treatment of atopic dermatitis 99
Oxidative stress in the pathogenesis of vitiligo 97
Efficacy of Electrochemotherapy in the Treatment of Cutaneous Melanoma Metastases and Rare Non-melanoma Skin Cancer 91
Mitochondrial Damage and Apoptosis in Keratinocytes from Perilesional Vitiligo Skin: Protective Effects of Curcumin and Capsaicin 90
Treatment of severe nail psoriasis with acitretin: An impressive therapeutic result 89
Reply: adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature 89
Oxidative stress markers in psoriatic patients plasma and NADPH oxidase as a source of oxidative stress in fibroblasts 86
Ultrastructural mitochondrial alterations and oxidative damage in keratinocytes from perilesional vitiligo skin 85
The role of Smac/DIABLO, p53, NF-kB, and MAPKs in Apoptosis of Keratinocytes from Perilesional Vitiligo Skin: Protective Effects of Curcumin and Capsaicin. 83
Vitiligo: Ultrastructure, oxidative stress and apoptosis in perilesional skin 82
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study 39
Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation 24
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics 24
Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas 23
Risankizumab in very elderly patients in real-world practice 18
Efficacy of ustekinumab in sub-erythrodermic psoriasis: when TNF-blockers fail 18
Risankizumab in Oncologic Patients With Psoriasis: A Case Series 16
Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study 14
Etanercept restores a differentiated keratinocyte phenotype in psoriatic human skin: a morphological study 13
Etanercept therapy in a hepatitis B virus (HBV)‐positive psoriatic patient developing a monoclonal gammopathy of undetermined significance 11
Deficiency of serum concentration of 25-hydroxyvitamin D correlates with severity of disease in chronic plaque psoriasis 10
Development of monoclonal gammopathy in 12 patients receiving efalizumab treatment for chronic plaque psoriasis 9
Reply 8
Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients 8
Development of MGUS in psoriatic patients: a possible undiagnosed event during anti‐TNF‐α‐treatment 8
Totale 5.888
Categoria #
all - tutte 17.633
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.633


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 0 0 0 0 0 12 13
2021/2022273 9 11 12 1 2 35 24 19 6 17 69 68
2022/2023778 64 188 42 54 62 141 75 40 75 2 19 16
2023/2024206 15 21 44 7 10 11 9 50 1 8 23 7
2024/20251.907 96 199 123 242 674 253 13 57 90 39 61 60
2025/20261.910 202 253 165 241 262 45 198 87 198 168 91 0
Totale 5.888